Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.

Tesfaye W, Krass I, Sud K, Johnson DW, Van C, Versace VL, McMorrow R, Fethney J, Mullan J, Tran A, Robson B, Vagholkar S, Kairaitis L, Gisev N, Fathima M, Tong V, Coric N, Castelino RL

Open source

DOI
10.1136/bmjopen-2023-079110
Published
2023 Dec 20
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2023-079110,
  title = {Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.},
  author = {Tesfaye W and Krass I and Sud K and Johnson DW and Van C and Versace VL and McMorrow R and Fethney J and Mullan J and Tran A and Robson B and Vagholkar S and Kairaitis L and Gisev N and Fathima M and Tong V and Coric N and Castelino RL},
  year = {2023},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2023-079110},
  url = {https://doi.org/10.1136/bmjopen-2023-079110}
}

RIS

TY  - JOUR
TI  - Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
AU  - Tesfaye W
AU  - Krass I
AU  - Sud K
AU  - Johnson DW
AU  - Van C
AU  - Versace VL
AU  - McMorrow R
AU  - Fethney J
AU  - Mullan J
AU  - Tran A
AU  - Robson B
AU  - Vagholkar S
AU  - Kairaitis L
AU  - Gisev N
AU  - Fathima M
AU  - Tong V
AU  - Coric N
AU  - Castelino RL
PY  - 2023
JO  - BMJ open
DO  - 10.1136/bmjopen-2023-079110
UR  - https://doi.org/10.1136/bmjopen-2023-079110
ER  - 

APA

W, T., I, K., K, S., DW, J., C, V., VL, V., R, M., J, F., J, M., A, T., B, R., S, V., L, K., N, G., M, F., V, T., N, C., & RL, C. (2023). Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2023-079110

Source records